GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Pretax Margin %

International Biotechnology Trust (LSE:IBT) Pretax Margin % : 96.30% (As of Aug. 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. International Biotechnology Trust's Pre-Tax Income for the six months ended in Aug. 2024 was £10.61 Mil. International Biotechnology Trust's Revenue for the six months ended in Aug. 2024 was £11.02 Mil. Therefore, International Biotechnology Trust's pretax margin for the quarter that ended in Aug. 2024 was 96.30%.

The historical rank and industry rank for International Biotechnology Trust's Pretax Margin % or its related term are showing as below:

LSE:IBT' s Pretax Margin % Range Over the Past 10 Years
Min: 81.65   Med: 97.93   Max: 117.27
Current: 97.19


LSE:IBT's Pretax Margin % is ranked better than
97.63% of 1013 companies
in the Biotechnology industry
Industry Median: -148.6 vs LSE:IBT: 97.19

International Biotechnology Trust Pretax Margin % Historical Data

The historical data trend for International Biotechnology Trust's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Pretax Margin % Chart

International Biotechnology Trust Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98.08 96.31 105.77 81.65 97.19

International Biotechnology Trust Semi-Annual Data
Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.61 96.27 109.80 97.52 96.30

Competitive Comparison of International Biotechnology Trust's Pretax Margin %

For the Biotechnology subindustry, International Biotechnology Trust's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Pretax Margin % falls into.



International Biotechnology Trust Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

International Biotechnology Trust's Pretax Margin for the fiscal year that ended in Aug. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Aug. 2024 )/Revenue (A: Aug. 2024 )
=39.011/40.14
=97.19 %

International Biotechnology Trust's Pretax Margin for the quarter that ended in Aug. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Aug. 2024 )/Revenue (Q: Aug. 2024 )
=10.607/11.015
=96.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


International Biotechnology Trust  (LSE:IBT) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


International Biotechnology Trust Pretax Margin % Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust Headlines

No Headlines